Nanoparticles for immunotherapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 20, 2011
Grant Date -
Feb 7, 2008
app pub date -
Feb 19, 2007
filing date -
Feb 21, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully